Found: 163
Select item for more details and to access through your institution.
Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5238, doi. 10.3390/jcm13175238
- By:
- Publication type:
- Article
Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 3095, doi. 10.3390/cancers16173095
- By:
- Publication type:
- Article
Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study.
- Published in:
- Frontiers in Public Health, 2024, p. 01, doi. 10.3389/fpubh.2024.1415334
- By:
- Publication type:
- Article
Tumour-infiltrating lymphocyte and histological regression in primary melanoma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 3, p. 333, doi. 10.3390/cells11030333
- By:
- Publication type:
- Article
Prevalence, types and comorbidity of mental disorders in a Kenyan primary health centre.
- Published in:
- Social Psychiatry & Psychiatric Epidemiology, 2014, v. 49, n. 8, p. 1257, doi. 10.1007/s00127-013-0755-2
- By:
- Publication type:
- Article
The Skin Microbiome and Its Role in Psoriasis: A Review.
- Published in:
- Psoriasis: Targets & Therapy, 2023, v. 13, p. 71, doi. 10.2147/PTT.S328439
- By:
- Publication type:
- Article
Low‐dose oral minoxidil in women affected by traction alopecia: real‐world outcomes.
- Published in:
- International Journal of Dermatology, 2024, v. 63, n. 8, p. 1113, doi. 10.1111/ijd.17234
- By:
- Publication type:
- Article
Drug survival, effectiveness, and safety of brodalumab for moderate‐to‐severe psoriasis up to 3 years.
- Published in:
- International Journal of Dermatology, 2024, v. 63, n. 7, p. 922, doi. 10.1111/ijd.17038
- By:
- Publication type:
- Article
Attitudes, characteristics, and occupational‐related risk of skin cancer and cutaneous melanoma in the militaries: an observational, cross‐sectional, survey‐based study.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 3, p. e167, doi. 10.1111/ijd.16439
- By:
- Publication type:
- Article
Nonmelanoma skin cancer arising on tattoos.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 3, p. e155, doi. 10.1111/ijd.16381
- By:
- Publication type:
- Article
Long‐term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 12, p. 1543, doi. 10.1111/ijd.16192
- By:
- Publication type:
- Article
SARS‐CoV‐2 vaccine‐related cutaneous manifestations: a systematic review.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 10, p. 1187, doi. 10.1111/ijd.16063
- By:
- Publication type:
- Article
Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related?
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 10, p. e370, doi. 10.1111/ijd.16022
- By:
- Publication type:
- Article
Treatment of eosinophilic pustular folliculitis with low‐dose isotretinoin.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 7, p. e262, doi. 10.1111/ijd.15929
- By:
- Publication type:
- Article
Certolizumab pegol and its role in pregnancy‐age hidradenitis suppurativa.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 5, p. e182, doi. 10.1111/ijd.15742
- By:
- Publication type:
- Article
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome.
- Published in:
- International Journal of Dermatology, 2015, v. 54, n. 9, p. 1023, doi. 10.1111/ijd.12730
- By:
- Publication type:
- Article
Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis.
- Published in:
- Cosmetics (2079-9284), 2024, v. 11, n. 1, p. 3, doi. 10.3390/cosmetics11010003
- By:
- Publication type:
- Article
Long-Term Efficacy and Safety of Dupilumab in Patients with Atopic Dermatitis: A Single-Centre Retrospective Study.
- Published in:
- Cosmetics (2079-9284), 2023, v. 10, n. 6, p. 153, doi. 10.3390/cosmetics10060153
- By:
- Publication type:
- Article
Anti‐IL17 Secukinumab in hidradenitis suppurativa: A long‐term drug survival analysis.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 7, p. 1, doi. 10.1111/exd.15140
- By:
- Publication type:
- Article
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 12, p. 2187, doi. 10.1111/exd.14731
- By:
- Publication type:
- Article
Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real‐life experience on 638 patients with psoriasis.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 9, p. 1591, doi. 10.1111/exd.14874
- By:
- Publication type:
- Article
Long‐term psychological outcome of patients with moderate‐to‐severe atopic dermatitis continuously treated with Dupilumab: Data up to 3 years.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 6, p. 852, doi. 10.1111/exd.14786
- By:
- Publication type:
- Article
Head and neck severity index is associated to a significant worsening of quality of life in atopic dermatitis patients.
- Published in:
- Experimental Dermatology, 2021, v. 30, n. 11, p. 1717, doi. 10.1111/exd.14368
- By:
- Publication type:
- Article
Alopecia areata after COVID-19 vaccination.
- Published in:
- Clinical & Experimental Vaccine Research, 2022, v. 11, n. 1, p. 129, doi. 10.7774/cevr.2022.11.1.129
- By:
- Publication type:
- Article
Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.672797
- By:
- Publication type:
- Article
In Vivo Observation of Cutaneous Larva Migrans by Fluorescence-Advanced Videodermatoscopy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
In Vivo Observation of Trombiculosis with Fluorescence-Advanced Videodermatoscopy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis.
- Published in:
- Dermatology Reports, 2022, v. 14, n. 3, p. 1, doi. 10.4081/dr.2022.9282
- By:
- Publication type:
- Article
Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4561, doi. 10.3390/ijms22094561
- By:
- Publication type:
- Article
The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI).
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 8, p. 3826, doi. 10.3390/ijms22083826
- By:
- Publication type:
- Article
The Cutaneous Spectrum of Lupus Erythematosus.
- Published in:
- Clinical Reviews in Allergy & Immunology, 2017, v. 53, n. 3, p. 291, doi. 10.1007/s12016-017-8627-2
- By:
- Publication type:
- Article
Head-neck melanoma: Clinical, histopathological and prognostic features of an Italian multicentric study.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 1, p. 76, doi. 10.1002/jvc2.250
- By:
- Publication type:
- Article
Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas.
- Published in:
- Oncology Letters, 2018, v. 16, n. 6, p. 7091, doi. 10.3892/ol.2018.9560
- By:
- Publication type:
- Article
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status A Systematic Review and Meta-analysis.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 12, p. 1301, doi. 10.1001/jamadermatol.2015.2235
- By:
- Publication type:
- Article
Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.00776
- By:
- Publication type:
- Article
Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/1793535
- By:
- Publication type:
- Article
Intraclass Switching among IL17 Inhibitors in Psoriasis: A Real-Life, Long-Term Single-Center Experience.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/5557255
- By:
- Publication type:
- Article
Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15917
- By:
- Publication type:
- Article
Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15866
- By:
- Publication type:
- Article
Tildrakizumab in real‐life shows good efficacy in moderate‐to‐severe psoriasis regardless of previous use of biologic drugs and joint involvement.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15818
- By:
- Publication type:
- Article
Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost‐effectiveness?
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15803
- By:
- Publication type:
- Article
Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15740
- By:
- Publication type:
- Article
Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real‐life study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15670
- By:
- Publication type:
- Article
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice?
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 9, p. 1, doi. 10.1111/dth.15697
- By:
- Publication type:
- Article
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 7, p. 1, doi. 10.1111/dth.15559
- By:
- Publication type:
- Article
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 6, p. 1, doi. 10.1111/dth.15492
- By:
- Publication type:
- Article
Persistent eruptive lentiginosis in a psoriatic patient after 4‐year effective treatment with ustekinumab.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 6, p. 1, doi. 10.1111/dth.15468
- By:
- Publication type:
- Article
Impact on health‐related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate‐to‐severe atopic dermatitis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 5, p. 1, doi. 10.1111/dth.15407
- By:
- Publication type:
- Article